These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 25471588)

  • 1. Noninvasive bioluminescence imaging of α-synuclein oligomerization in mouse brain using split firefly luciferase reporters.
    Aelvoet SA; Ibrahimi A; Macchi F; Gijsbers R; Van den Haute C; Debyser Z; Baekelandt V
    J Neurosci; 2014 Dec; 34(49):16518-32. PubMed ID: 25471588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bimolecular Fluorescence Complementation of Alpha-synuclein Demonstrates its Oligomerization with Dopaminergic Phenotype in Mice.
    Cai W; Feng D; Schwarzschild MA; McLean PJ; Chen X
    EBioMedicine; 2018 Mar; 29():13-22. PubMed ID: 29433982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tea polyphenols alleviate motor impairments, dopaminergic neuronal injury, and cerebral α-synuclein aggregation in MPTP-intoxicated parkinsonian monkeys.
    Chen M; Wang T; Yue F; Li X; Wang P; Li Y; Chan P; Yu S
    Neuroscience; 2015 Feb; 286():383-92. PubMed ID: 25498223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of FABP3 ligands that inhibit arachidonic acid-induced α-synuclein oligomerization.
    Cheng A; Shinoda Y; Yamamoto T; Miyachi H; Fukunaga K
    Brain Res; 2019 Mar; 1707():190-197. PubMed ID: 30496735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sigma-1 receptor knockout increases α-synuclein aggregation and phosphorylation with loss of dopaminergic neurons in substantia nigra.
    Hong J; Wang L; Zhang T; Zhang B; Chen L
    Neurobiol Aging; 2017 Nov; 59():171-183. PubMed ID: 28870519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Rapid, Semi-Quantitative Assay to Screen for Modulators of Alpha-Synuclein Oligomerization Ex vivo.
    Delenclos M; Trendafilova T; Jones DR; Moussaud S; Baine AM; Yue M; Hirst WD; McLean PJ
    Front Neurosci; 2015; 9():511. PubMed ID: 26834539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
    Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
    J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of α-Synuclein Protein Levels by an Intracellular Single-Chain Antibody.
    Chen YH; Yu SJ; Wu KJ; Wang YS; Tsai HM; Liao LW; Chen S; Hsieh W; Chen H; Hsu SC; Chen ML; Hoffer BJ; Wang Y
    J Parkinsons Dis; 2020; 10(2):573-590. PubMed ID: 32176654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Effect of β-Wrapin AS69 in a Mouse Model Based on Alpha-Synuclein Overexpression.
    Höfs L; Geißler-Lösch D; Wunderlich KM; Szegö EM; Van den Haute C; Baekelandt V; Hoyer W; Falkenburger BH
    Biomolecules; 2024 Jun; 14(7):. PubMed ID: 39062470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress-induced posttranslational modifications of alpha-synuclein: specific modification of alpha-synuclein by 4-hydroxy-2-nonenal increases dopaminergic toxicity.
    Xiang W; Schlachetzki JC; Helling S; Bussmann JC; Berlinghof M; Schäffer TE; Marcus K; Winkler J; Klucken J; Becker CM
    Mol Cell Neurosci; 2013 May; 54():71-83. PubMed ID: 23369945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-expression of C-terminal truncated alpha-synuclein enhances full-length alpha-synuclein-induced pathology.
    Ulusoy A; Febbraro F; Jensen PH; Kirik D; Romero-Ramos M
    Eur J Neurosci; 2010 Aug; 32(3):409-22. PubMed ID: 20704592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of MPTP-induced α-synuclein oligomerization by fatty acid-binding protein 3 ligand in MPTP-treated mice.
    Matsuo K; Cheng A; Yabuki Y; Takahata I; Miyachi H; Fukunaga K
    Neuropharmacology; 2019 May; 150():164-174. PubMed ID: 30930168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FABP3 protein promotes α-synuclein oligomerization associated with 1-methyl-1,2,3,6-tetrahydropiridine-induced neurotoxicity.
    Shioda N; Yabuki Y; Kobayashi Y; Onozato M; Owada Y; Fukunaga K
    J Biol Chem; 2014 Jul; 289(27):18957-65. PubMed ID: 24855640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex and Age Differences in a Progressive Synucleinopathy Mouse Model.
    Lamontagne-Proulx J; Coulombe K; Morissette M; Rieux M; Calon F; Di Paolo T; Soulet D
    Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration.
    Paumier KL; Luk KC; Manfredsson FP; Kanaan NM; Lipton JW; Collier TJ; Steece-Collier K; Kemp CJ; Celano S; Schulz E; Sandoval IM; Fleming S; Dirr E; Polinski NK; Trojanowski JQ; Lee VM; Sortwell CE
    Neurobiol Dis; 2015 Oct; 82():185-199. PubMed ID: 26093169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboxy-terminal truncations of mouse α-synuclein alter aggregation and prion-like seeding.
    Sorrentino ZA; Xia Y; Gorion KM; Hass E; Giasson BI
    FEBS Lett; 2020 Apr; 594(8):1271-1283. PubMed ID: 31912891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manganese promotes the aggregation and prion-like cell-to-cell exosomal transmission of α-synuclein.
    Harischandra DS; Rokad D; Neal ML; Ghaisas S; Manne S; Sarkar S; Panicker N; Zenitsky G; Jin H; Lewis M; Huang X; Anantharam V; Kanthasamy A; Kanthasamy AG
    Sci Signal; 2019 Mar; 12(572):. PubMed ID: 30862700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of α-synuclein propagation after intrastriatal injection in FABP3 null mice.
    Matsuo K; Kawahata I; Melki R; Bousset L; Owada Y; Fukunaga K
    Brain Res; 2021 Jun; 1760():147383. PubMed ID: 33636166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain-permeable small-molecule inhibitors of Hsp90 prevent alpha-synuclein oligomer formation and rescue alpha-synuclein-induced toxicity.
    Putcha P; Danzer KM; Kranich LR; Scott A; Silinski M; Mabbett S; Hicks CD; Veal JM; Steed PM; Hyman BT; McLean PJ
    J Pharmacol Exp Ther; 2010 Mar; 332(3):849-57. PubMed ID: 19934398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallate.
    Mandel S; Maor G; Youdim MB
    J Mol Neurosci; 2004; 24(3):401-16. PubMed ID: 15655262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.